US
Europe (English)
Chinese
Japanese-
Next Generation Sequencing
-
RNA-SeqSingle-Cell RNA SequencingAmplicon Sequencing ServicesCRISPR ValidationWhole Genome SequencingSequencing Only
Exome SequencingTargeted SequencingMetagenomicsEpigenomicsImmunogenomics
-
-
Sanger Sequencing
-
Purified TemplatesDifficult Template SequencingDirect Colony SequencingPCR PurificationPremium Services
-
-
Gene Synthesis
-
Standard Gene Synthesis (PriorityGENE)TurboGENE™FragmentGENESynthetic DNA LibrariesCRISPR Construct SynthesisssDNA Synthesis NewDNA CloningSite-Directed Mutagenesis
-
-
Molecular Genetics
-
Bacterial and Fungal IdentificationMutation AnalysisSNP GenotypingPCR Plus Sequencing CRISPR Analysis PackageConfirmatory Sequencing & Cell Bank CharacterizationYeast Colony SequencingFragment Analysis
-
-
Plasmid DNA Preparation
-
Standard Plasmid DNA PreparationTargeted Yield Plasmid DNA Preparation
-
-
Oligo Synthesis Services
-
Oligo-Rapid SynthesisOligo-Flex SynthesisOligo Retained for Sanger Sequencing
-
-
GLP-Compliant Services
-
Confirmatory SequencingSNP Mutation Analysis
Plasmid Prep
Nucleic Acid Extraction
-
-
Clinical Services NEW
-
CLIA Variant Confirmation (PCR + Sanger)CLIA Sanger SequencingCLIA Whole Exome SequencingCLIA Whole Genome Sequencing
-
Solid Science. Superior Service.
About Us
As a global leader in R&D genomics services, GENEWIZ leads the way in providing superior data quality with unparalleled technical support to enable researchers around the world to advance their scientific discoveries faster than ever before.
Our customers at top-tier pharmaceutical, biotechnology, and academic institutions, as well as cutting-edge start-ups, rely on GENEWIZ's proprietary technologies for consistent, reliable, high-quality data, even on the most difficult projects. A full-service provider, GENEWIZ provides Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next generation sequencing, bioinformatics, and GLP regulatory services.
Since the company's beginning in 1999 as a start-up in a 200 square foot, sub-leased laboratory, GENEWIZ has maintained an unwavering commitment to increase research productivity through fast, reliable delivery of quality results, competitive prices, excellent project management, and easy access to expert technical support when needed, at no charge.
GENEWIZ has a growing network of genomics laboratories around the world. Our customers are supported by state-of-the-art facilities and highly qualified scientific teams. GENEWIZ Regulatory Services, located in South Plainfield, NJ, are subject to rigorous quality systems based on Good Laboratory Practice (GLP), Clinical Laboratory Improvement Amendments (CLIA) regulations and College of American Pathologist (CAP) standards. GENEWIZ Suzhou, China and Takeley, UK locations also hold the ISO:9001 Quality Management Certification, a voluntary international certification noting operational excellence and quality standards.
Headquartered in South Plainfield, NJ, GENEWIZ is privately-held with a global network of laboratories in Boston, MA; Washington, DC Metro; Research Triangle Park, NC; San Diego, CA; Los Angeles, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, Suzhou, Tanjin, and Guangzhou China; Takeley, United Kingdom; and Tokyo, Japan.
Mission & VISION
The mission of GENEWIZ is to contribute to the advancement of life sciences and technologies by making research more productive and cost efficient through our scalable services.
Our vision is to make GENEWIZ the partner of choice for life science research communities around the world. Together we can make a difference in the pursuit of scientific discoveries, better medicines, a greener environment, and abundant and healthy food supplies.
2016 AWARDS
Frost & Sullivan 2016 Best Practice Award
North America Life Science Research Services Company of the Year Award
GENEWIZ is the recipient of the Frost & Sullivan 2016 North America Life Science Research Services Company of the Year Award. The award recognizes GENEWIZ as the industry leader based on its consistent stellar growth, strategic investments to expand infrastructure, and being a cutting-edge genomics service provider; all while ensuring its customers receive best-in-class service.
Download Full ReportINDUSTRY AWARDS
